New publication of GPF as a biomarker of Covid-19

Written By Sofia Villar

Gamma Diagnostics is excited to announce that our study γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity has been published in Blood Cells, Molecules and Diseases.

Please click below to read the study.

Sofia Villar
Previous

Afri Grow Partners with Gamma Diagnostics
Next

Gamma Diagnostics and OHSU Announce a Licensing Agreement